Acute kidney injury (AKI) is estimated to occur in up to 50% of patients with liver cirrhosis and is associated with increased morbidity and a high risk of short-term and long-term mortality.1 ...

A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver disease (MASLD), a chronic liver condition that ...

A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Researchers across 14 medical centers in China, including Peking University People's Hospital, have found that an ...